First communication from APVMA to DAFF regarding registered products

Written by Claude Haiku 5.5 from the extracted text on 14 Oct 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

This release comprises five pages of internal APVMA and DAFF correspondence, chiefly a Microsoft Teams calendar invitation for a monthly APVMA | DAFF meeting on 10 March 2026, a short agenda and an executive catch-up note listing "Chemical reconsideration/prioritisation" as an APVMA addition. The most substantive content is a set of working notes on registration policy for agricultural and veterinary chemical products. These record that the APVMA is considering how to handle multi-strain vaccines without registering each strain as a separate active, and that it has found it cannot do so under current arrangements. The notes estimate that 11 per cent of agricultural and 4 per cent of veterinary products have multiple formulations registered against a single product, and that about 50 applications seek to vary these. The notes attribute much of this to arrangements inherited from state systems and report no safety, environmental or trade concerns. Some text is redacted.